![Frank L. Porfido](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank L. Porfido
Keine laufenden Positionen mehr
Profil
Frank L.
Porfido held the position of Chief Financial Officer at Tyme Technologies, Inc. in 2021 and Vice President-Finance at UroGen Pharma, Inc. from 2019 to 2021.
He earned an MBA from Fairleigh Dickinson University and an undergraduate degree from Pace University.
Ehemalige bekannte Positionen von Frank L. Porfido
| Unternehmen | Position | Ende |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Finanzdirektor/CFO | 16.09.2022 |
UroGen Pharma, Inc.
 UroGen Pharma, Inc. BiotechnologyHealth Technology Operates as a biotech company that developing and commercializing innovative solutions to treat urothelial and specialty cancers | Corporate Officer/Principal | 01.05.2021 |
Ausbildung von Frank L. Porfido
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UroGen Pharma, Inc.
UroGen Pharma, Inc. BiotechnologyHealth Technology Operates as a biotech company that developing and commercializing innovative solutions to treat urothelial and specialty cancers | Health Technology |
Wählen Sie MarketScreener 
